Invitae to Present at the UBS Genomics 2.0 and MedTech Innovations Summit

Invitae Corporation (NYSE: NVTA) announced its participation in the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021.

Rhea-AI Summary

Invitae Corporation (NYSE: NVTA) announced its participation in the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021. The management team will engage in a fireside chat at 11:00 a.m. PT, while CEO Sean George will join the NGS Technologies panel at 1:00 p.m. PT. Interested investors can access live webcasts through the company’s investor relations site, with replays available shortly after the events. Invitae aims to integrate comprehensive genetic information into healthcare, enhancing test quality and accessibility.

Argus Session date unavailable

-7.29% session move Open Argus

Details

News Market Reaction – NVTA

The recorded move for NVTA in the trading session of this news was -7.29%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO, Aug. 9, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in a fireside chat at the UBS Genomics 2.0 and MedTech Innovations Summit on Wednesday, August 11, 2021 at 11:00 a.m. PT and Sean George, chief executive officer of Invitae, will participate in the NGS Technologies panel presentation at 1:00 p.m. PT, both at Montage Laguna Beach.

The live webcasts of the fireside chat and the panel presentation may be accessed by visiting the investors section of the company website at ir.invitae.com. Replays of the webcasts will be available shortly after the conclusion of the fireside chat and panel presentation.

About Invitae

Invitae Corporation (NYSE: NVTA) is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company's website at invitae.com.

Contact:
ir@invitae.com
(628) 213-3369

View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-the-ubs-genomics-2-0-and-medtech-innovations-summit-301351402.html

SOURCE Invitae Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Invitae's participation in the UBS Genomics 2.0 and MedTech Innovations Summit?

Invitae Corporation will participate in the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021.

What will Invitae's management team present at the UBS Summit?

Invitae's management will conduct a fireside chat at 11:00 a.m. PT and CEO Sean George will join the NGS Technologies panel at 1:00 p.m. PT.

How can investors access the live webcasts of Invitae's presentations?

Investors can access the live webcasts on Invitae's investor relations website.

What is the stock symbol for Invitae Corporation?

The stock symbol for Invitae Corporation is NVTA.

What is Invitae Corporation's mission?

Invitae's mission is to bring comprehensive genetic information into mainstream medical practice to improve healthcare for billions of people.